Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Homologous vs Heterologous COVID-19 Vaccination in Hemodialysis Patients
TCTR20220516002Completed
- Sponsor
- Faculty of Medicine, Chiang Mai University
- Start
- Jul 2021
- Countries
- 1
01
Overview
Open-label trial in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Faculty of Medicine, Chiang Mai University. Primary endpoints: Immunogenicity and Safety. Started Jul 2021; status: completed.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20220516002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220516002.